fda semaglutide approval Approves for New Indication Involving Cardiovascular Disease semaglutide approval date What's next

These likely include: Personal or family history of medullary thyroid cancer Multiple endocrine neoplasia syndrome type 2 Severe kidney or liver disease Active gallbladder disease If youre pregnant or breastfeeding People taking certain medications might not be good candidates

Quick Takeaways Fat transport: helps carry fat into mitochondria where it can be used for energy

Gastrointestinal adverse events Compared with placebo, all doses of tirzepatide and semaglutide demonstrated an increase in the risk for nausea (ESM Fig

A recent meta-analysis that reviewed multiple studies came to the same conclusion, stating that tirzepatide showed superior results for both blood sugar control and weight reduction

It's important to work closely with your healthcare provider to ensure the medication is right for you and to monitor your response